Security Snapshot

ABEONA THERAPEUTICS INC - COM NEW Institutional Ownership

CUSIP: 00289Y206

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / COM NEW
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • 00289Y206 - ABEONA THERAPEUTICS INC - COM NEW is tracked under CUSIP 00289Y206.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 2 to 1 between Q2 2024 and Q3 2024.
  • Reported value moved from $2,579,337 to $1,006,744.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 00289Y206?
CUSIP 00289Y206 identifies 00289Y206 - ABEONA THERAPEUTICS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of ABEONA THERAPEUTICS INC - COM NEW across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 159,295 $1,006,744 -$16,432 $6.32 1
2024 Q2 608,334 $2,579,337 +$1,279,590 $4.24 2
2024 Q1 306,544 $2,222,445 +$313,019 $7.25 2
2023 Q4 263,369 $1,319,478 $5.01 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .